Knowledge markets or knowledge spillovers in Canadian Human Health Biotechnology. Johanne Queenton UQAM, Canada Research Chair in MOT ISRN 6 th Annual Meeting, Vancouver May 15, 2004. Knowledge economy.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Knowledge markets or knowledge spillovers in Canadian Human Health Biotechnology
UQAM, Canada Research Chair in MOT
ISRN 6th Annual Meeting, Vancouver
May 15, 2004
Access to relations with strong intensity of knowledge (Foray, 2000) = Competitive advantage
Innovation sources : Interactions between firm scientists, universities and public institutions (Powell, 1996).
Key feature: Interdependence in the development of technological innovations
Study of two forms:
2. Movement of people: Interactions are more geographically delimited when a bioscientist is really involved in the creation of a SBFs (Audretsch & Stephan, 1996)
« Knowledge spillovers geographically delimited allowing near important knowledge sources to introduce more rapidly innovations than firms located elsewhere » (Breschi & Lissoni, 2001).
« Pure knowledge externalities do not applied in biotechnology, it is more and more market and non-market transactions » (Zucker et al., 1998).
« More and more contractual and proprietary links in competitive markets » (Zucker et al., 1998)
Specific types of links of bioscientists with SBFs
Database on Canadian SBFs in human health: Sampling with assignees patents
Goal: Relate knowledge flows within innovation systems and biotechnology clusters
Sources: Canadian Biotech. Directory 2001,2002, B2B Industry Guide - Contact Canada, Canadian Biotech. Firms Annual Reports, SBFs Web Sites, Strategis – Industry Canada, Statistics Canada
3 types of involved researchers in economic development of biotechnology:
Type of externality in biotechnology: + than just knowledge spillovers , + and + market and non-market transactions
Among the studied population:
Measures of 2 I (innovation & interdependence)
Innovation: Canadian SBFs Patents
Interdependence: interaction of scientific & technological development, entrepreneurship – central in biotechnology
Involved stakeholders - Connections
Contractactual Relationships or proprietary links
Challenges in competitive markets
Research: Definition of researchers categories
Star Scientists Typology Bio-Scientists Typology